共 223 条
[1]
Berenson JR(2006)Treatment strategies for skeletal complications of cancer Cancer Biol Ther 5 1074-1077
[2]
Rajdev L(2011)Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study Lancet 377 813-822
[3]
Broder M(2003)Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 1115-1117
[4]
Fizazi K(2017)Denosumab-related osteonecrosis of the jaw in a patient with bone metastases of prostate cancer: a case report and literature review Oncol Lett 14 127-136
[5]
Carducci M(2008)Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people J Am Dent Assoc 139 23-30
[6]
Smith M(2002)Zoledronate once-yearly increases bone mineral density—implications for osteoporosis Expert Opin Pharmacother 3 1007-1009
[7]
Damião R(2010)Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series J Oral Maxillofac Surg 68 107-110
[8]
Brown J(2013)Tooth extractions in intravenous bisphosphonate-treated patients: a refined protocol J Oral Maxillofac Surg 71 994-999
[9]
Karsh L(2014)American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update J Oral Maxillofac Surg 72 1938-1956
[10]
Milecki P(2010)Bisphosphonate-related osteonecrosis of the jaw: position paper from the allied task force committee of Japanese society for bone and mineral research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons J Bone Miner Metab 28 365-383